Dublin medtech firm's remote monitoring platform cuts health costs by 92% in clinical trial

A Dublin-based digital health company specialising in remote patient monitoring has seen independent researchers confirm its platform delivers substantial reductions in both health service costs and outpatient appointments.

According to a report by Irish Tech News, the findings were confirmed in a randomised controlled trial conducted by researchers at Manchester University NHS Foundation Trust and The University of Manchester, with results published in The Journal of Heart and Lung Transplantation. The trial examined the use of patientMpower's remote monitoring technology in lung transplant patients.

The study found that the need for clinic visits was reduced by 80% when patientMpower's technology was used to remotely assess patients' health parameters and symptoms, alongside a 92% reduction in health service costs compared to standard clinic-based care. Patients also reported average travel time savings of six hours, with no differences in symptoms, clinical parameters, adverse events, or unscheduled visits between groups, indicating that care quality was maintained throughout.

The results build on earlier randomised controlled trial findings, including a separate study in which patientMpower's platform reduced hospitalisations in patients with chronic obstructive pulmonary disease by 82%. A trial at Tallaght Hospital produced consistent findings, further reinforcing the platform's clinical evidence base across multiple conditions.

Founded in 2015 and headquartered at The Digital Hub in Dublin 8, patientMpower's technology is currently deployed across seven countries and supports the monitoring of patients with respiratory, heart, and kidney conditions, as well as those in maternity care. Its client base includes ERASMUS MC in Rotterdam, UZ Leuven in Belgium, and NYU Langone Health in New York.

Manchester University NHS Foundation Trust has since renegotiated its agreement with patientMpower, extending the platform across new care pathways with more than 1,000 patients now under management. The solution has also been integrated with Epic, Manchester's electronic health record system, further embedding the technology into clinical workflows.

Eamonn Costello, CEO of patientMpower, said: "Our technology reduces pressure on outpatient and integrated care services, and prevents acute admissions, by enabling care teams to deliver the level of patient-centred care they cannot provide with traditional models."

Discover the full trial findings and what they mean for the future of remote patient monitoring in the complete article.